MTPConnect has adopted a new name as it enters its second decade, rebranding itself as AUScelerate. The organisation said the change aims to better reflect its mission to commercialise Australian life sciences.
The announcement was made at the CSL Australian BIO 2026 Dinner in San Diego, ahead of the BIO International Convention, the world’s largest biotechnology partnering event.
Board Chair the Hon. Jaala Pulford said the change signals the organisation’s evolution and its growing role both domestically and internationally. "Our new name and bolder brand identity reflect the organisation’s evolution and better capture what we do, the value we create and the role we play — both here in Australia and on the global stage," said Pulford.
"And while the name AUScelerate may be new, our programs and commitment to supporting Australia’s life science innovators is not.
“We will continue delivering world-class accelerator and innovation programs, supporting early-stage biomedical and medtech development, connecting Australian companies to global markets and driving the commercialisation of breakthrough health and medical technologies.
“We remain at the heart of Australia's life sciences ecosystem, connecting capability, capital and commercial pathways from coast to coast and across the globe," said Pulford.
The new name was revealed during AUScelerate’s flagship BIO Conference welcome reception and dinner, held in partnership with the American Australian Association and supported by CSL. The event drew leaders and investors from Australia, the US, the UK, Canada, South Korea, the Kingdom of Saudi Arabia and Singapore.
Established by the Australian Government in 2015 under the Industry Growth Centres Initiative, MTPConnect transitioned to operate independently after government funding ended in 2022.
